Angel Pharmaceuticals is a biotech company focused on developing a pipeline of innovative medicines for cancer and autoimmune diseases. Angel Pharmaceuticals was launched with strategic collaboration with U.S. biopharmaceutical company Corvus Pharmaceuticals, Inc., with investments from Puissance Capital, Hisun Pharmaceuticals, Tigermed and fund associated with Betta Pharmaceuticals.

Angel Pharmaceuticals' research and development facilities are mainly located in Jiaxing, Zhejiang Province, China. The company has assembled a team experienced in clinical development and pre-clinical research.